Logo-bi
Review
Pavankumar Kothamasu*, Hemanth Kanumur, Niranjan Ravur, Chiranjeevi Maddu, Radhika Parasuramrajam, Sivakumar Thangavel
Bioimpacts. 2012;2(2): 71-81. doi: 10.5681/bi.2012.011
PMCID: PMC3648923     PMID: 23678444     Scopus ID: 84876742237    
Review
Ailar Nakhlband, Jaleh Barar* ORCID
Bioimpacts. 2011;1(1): 7-22. doi: 10.5681/bi.2011.003
PMCID: PMC3648943     PMID: 23678403     Scopus ID: 84876715577    
PDF
XML
Cited By:
Original Research
Hassan Namazi*, Sanaz Motamedi, Mina Namvari
Bioimpacts. 2011;1(1): 63-69. doi: 10.5681/bi.2011.009
PMCID: PMC3648942     PMID: 23678409     Scopus ID: 84876698090    
PDF
XML
Cited By:
Review
Ali Nokhodchi*, Shaista Raja, Pryia Patel, Kofi Asare-Addo
Bioimpacts. 2012;2(4): 175-187. doi: 10.5681/bi.2012.027
PMCID: PMC3648939     PMID: 23678458     Scopus ID: 84876799240    
Short Communication
Savitri Shrestha, Sundara Rajan Subaramaihha, Sujan Ganapathy Pasura Subbaiah, Ravi Shankara Birur Eshwarappa*, Dhananjaya Bhadrapura Lakkappa*
Bioimpacts. 2013;3(4): 195-198. doi: 10.5681/bi.2013.035
PMCID: PMC3892739     PMID: 24455483     Scopus ID: 84893418224    
PDF
XML
Cited By:
Original Research
Amna Parveen, Muhammad Sajid Hamid Akash*, Kanwal Rehman, Qaisar Mehmood, Muhammad Imran Qadir*
Bioimpacts. 2014;4(1): 43-48. doi: 10.5681/bi.2014.013
PMCID: PMC4005283     PMID: 24790898     Scopus ID: 84900490170    
PDF
XML
Cited By:
Editorial
Miguel de la Guardia*
Bioimpacts. 2014;4(1): 1-2. doi: 10.5681/bi.2014.009
PMCID: PMC4005277     PMID: 24790892     Scopus ID: 84900478943    
PDF
XML
Cited By:
Original Research
Ravi Shankara Birur Eshwarappa, Raman Shanthi Iyer, Sundara Rajan Subbaramaiah, S Austin Richard, Bhadrapura Lakkappa Dhananjaya*
Bioimpacts. 2014;4(2): 101-107. doi: 10.5681/bi.2014.018
PMCID: PMC4097971     PMID: 25035854     Scopus ID: 84905505791    
PDF
XML
Cited By:
Original Research
Hassan Namazi*, Yousef Toomari, Hassan Abbaspour
Bioimpacts. 2014;4(4): 175-182. doi: 10.15171/bi.2014.010
PMCID: PMC4298708     PMID: 25671173     Scopus ID: 84921000950    
PDF
XML
Cited By:
Review
Samira Jafari, Solmaz Maleki Dizaj, Khosro Adibkia*
Bioimpacts. 2015;5(2): 103-111. doi: 10.15171/bi.2015.10
PMCID: PMC4492185     PMID: 26191505     Scopus ID: 84930392449    
Original Research
Reza Heidari, Maryam Rasti, Babak Shirazi Yeganeh, Hossein Niknahad*, Arastoo Saeedi, Asma Najibi
Bioimpacts. 2016;6(1): 3-8. doi: 10.15171/bi.2016.01
PMCID: PMC4916549     PMID: 27340618     Scopus ID: 84977138520    
Editorial
Jaleh Barar* ORCID
Bioimpacts. 2015;5(3): 113-115. doi: 10.15171/bi.2015.23
PMCID: PMC4597157     PMID: 26457247     Scopus ID: 84944413654    
PDF
XML
Cited By:
Review
Sonu Gandhi*, Pankaj Suman, Ashok Kumar, Prince Sharma, Neena Capalash, C. Raman Suri
Bioimpacts. 2015;5(4): 207-213. doi: 10.15171/bi.2015.30
PMCID: PMC4769791     PMID: 26929925     Scopus ID: 84958175557    
Editorial
Azin Jahangiri, Khosro Adibkia*
Bioimpacts. 2016;6(1): 1-2. doi: 10.15171/bi.2016.08
PMCID: PMC4916546     PMID: 27340617     Scopus ID: 84977117587    
Review
Reza Safdari, Reza Ferdousi, Kamal Aziziheris, Sharareh R. Niakan-Kalhori, Yadollah Omidi* ORCID
Bioimpacts. 2016;6(2): 71-78. doi: 10.15171/bi.2016.10
PMCID: PMC4981251     PMID: 27525223     Scopus ID: 84983479545    
Editorial
Marzieh Fathi, Jaleh Barar ORCID, Ayuob Aghanejad, Yadollah Omidi* ORCID
Bioimpacts. 2015;5(4): 159-164. doi: 10.15171/bi.2015.31
PMCID: PMC4769784     PMID: 26929918     Scopus ID: 84958155033    
Original Research
Gerard Marshall Raj*, Jayanthi Mathaiyan*, Mukta Wyawahare, Katiboina Srinivasa Rao, Rekha Priyadarshini
Bioimpacts. 2017;7(1): 25-30. doi: 10.15171/bi.2017.04
PMCID: PMC5439386     PMID: 28546950     Scopus ID: 85019055600    
Review
Somayeh Vandghanooni, Morteza Eskandani*
Bioimpacts. 2011;1(2): 87-97. doi: 10.5681/bi.2011.012
PMCID: PMC3648950     PMID: 23678412     Scopus ID: 84874697767    
PDF
XML
Cited By:
Original Research
Behzad Jafari, Farzaneh Rafie, Soodabeh Davaran*
Bioimpacts. 2011;1(2): 135-143. doi: 10.5681/bi.2011.018
PMCID: PMC3648951     PMID: 23678418     Scopus ID: 84872944287    
PDF
XML
Cited By:
Review
Yadollah Omidi* ORCID, Jaleh Barar ORCID
Bioimpacts. 2012;2(1): 5-22. doi: 10.5681/bi.2012.002
PMCID: PMC3648919     PMID: 23678437     Scopus ID: 84876731279    
PDF
XML
Cited By:
Review
Jaleh Barar ORCID, Ayuob Aghanejad, Marziyeh Fathi, Yadollah Omidi* ORCID
Bioimpacts. 2016;6(1): 49-67. doi: 10.15171/bi.2016.07
PMCID: PMC4916551     PMID: 27340624     Scopus ID: 84977080654    
Review
Marziyeh Fathi, Jaleh Barar* ORCID
Bioimpacts. 2017;7(1): 49-57. doi: 10.15171/bi.2017.07
PMCID: PMC5439389     PMID: 28546953     Scopus ID: 85019106716    
Review
Jaleh Barar ORCID, Mohammad A. Rafi, Mohammad M. Pourseif, Yadollah Omidi* ORCID
Bioimpacts. 2016;6(4): 225-248. doi: 10.15171/bi.2016.30
PMCID: PMC5326671     PMID: 28265539     Scopus ID: 85013096202    
Original Research
Hassan Namazi*, Elnaz Abdollahzadeh
Bioimpacts. 2018;8(2): 99-106. doi: 10.15171/bi.2018.12
PMCID: PMC6026521     PMID: 29977831     Scopus ID: 85048075763    
Review
Marziyeh Fathi, Parham Sahandi Zangabad, Sima Majidi, Jaleh Barar, Hamid Erfan-Niya, Yadollah Omidi* ORCID
Bioimpacts. 2017;7(4): 269-277. doi: 10.15171/bi.2017.32
PMCID: PMC5801539     PMID: 29435435     Scopus ID: 85041008382    
Review
Shahram Emami, Mohammadreza Siahi-Shadbad, Khosro Adibkia ORCID, Mohammad Barzegar-Jalali*
Bioimpacts. 2018;8(4): 305-320. doi: 10.15171/bi.2018.33
PMCID: PMC6209825     PMID: 30397585     Scopus ID: 85056076769    
Editorial
Karim Osouli-Bostanabad, Khosro Adibkia* ORCID
Bioimpacts. 2018;8(2): 77-79. doi: 10.15171/bi.2018.09
PMCID: PMC6026524     PMID: 29977828     Scopus ID: 85048089691    
Review
Ailar Nakhlband, Morteza Eskandani, Yadollah Omidi ORCID, Nazli Saeedi, Samad Ghafari, Jaleh Barar* ORCID, Alireza Garjani*
Bioimpacts. 2018;8(1): 59-75. doi: 10.15171/bi.2018.08
PMCID: PMC5915710     PMID: 29713603     Scopus ID: 85044298919    
Original Research
Ayuob Aghanejad, Hiwa Babamiri, Khosro Adibkia, Jaleh Barar ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2018;8(2): 117-127. doi: 10.15171/bi.2018.14
PMCID: PMC6026525     PMID: 29977833     Scopus ID: 85048082430    
Original Research
Prayasee Baruah, Mostofa Ataur Rohman, Semen O. Yesylevskyy, Sivaprasad Mitra* ORCID
Bioimpacts. 2019;9(2): 79-88. doi: 10.15171/bi.2019.11
PMCID: PMC6637216     PMID: 31334039     Scopus ID: 85067466464    
Two chromone derivatives, CyC and AMC exhibit strong non-competitive acetylcholinesterase (AChE) inhibition. CyC, due to planarity and greater stacking interactions with Peripheral Anionic Site, is the stronger AChE antagonist and plasma protein binder.
Editorial
Somayeh Vandghanooni, Morteza Eskandani, Jaleh Barar ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2019;9(2): 67-70. doi: 10.15171/bi.2019.09
PMCID: PMC6637218     PMID: 31334037     Scopus ID: 85067455587    
Aptamers (Aps) are short single-strand nucleic acids, which can be used as the therapeutic and targeting agent in advanced drug delivery systems. Conjugation of Aps with other entities (siRNA, toxins, drugs, DNAzyme/Ribozymes) provides advanced multifunctional nanosystems for cancer therapy.
Original Research
Reza Ferdousi ORCID, Ali Akbar Jamali ORCID, Reza Safdari* ORCID
Bioimpacts. 2020;10(2): 97-104. doi: 10.34172/bi.2020.12
PMCID: PMC7186546     PMID: 32363153     Scopus ID: 85090696578    
The Market Basket Analysis (MBA) was used to identify bio-elements involved in the occurrence of drug-drug interactions (DDIs), which resulted in the identification of over 200,000 potential DDIs. The MBA can be used in the prediction of nonlinear biological issues.
Editorial
Marziyeh Fathi ORCID, Azam Safary ORCID, Jaleh Barar* ORCID
Bioimpacts. 2020;10(1): 1-4. doi: 10.15171/bi.2020.01
PMCID: PMC6977590     PMID: 31988850     Scopus ID: 85078980716    
Jaleh Barar (PharmD, PhD) is Professor of Drug Delivery and Targeting. She currently is the chair of the department of Pharmaceutics at the Faculty of Pharmacy, Tabriz university of Medical Sciences. Professor Barar’s research is focused on various aspects of the pharmaceutical cell biology with the particular emphasis on the development of novel drug delivery and targeting strategies to combat cancer.
Letter to the Editor COVID-19
Yosef Masoudi-Sobhanzadeh* ORCID
Bioimpacts. 2020;10(3): 205-206. doi: 10.34172/bi.2020.25
PMCID: PMC7416005     PMID: 32793443     Scopus ID: 85089710496    
This letter aims to introduce drug repurposing methods and the existing challenges to detect candidate drugs which may be helpful in controlling COVID-19.
Original Research
Amir Shakouri ORCID, Houman Kahroba, Hamed Hamishekar, Jalal Abdolalizadeh* ORCID
BioImpacts. 2022;12(2): 115-126. doi: 10.34172/bi.2021.39
PMCID: PMC8905592     PMID: 35411300     Scopus ID: 85126459418    
In the first stage of the procedure, medical leech saliva was extracted and for encapsulating these proteins, liposome technique was applied. Continually, nano drug applied on cancer cells and expression of genes were evaluated by Real- Time PCR and western blotting.
Original Article
Samira Gholizadeh ORCID, Hossein Haghaei, Hosna Karami, Somaieh Soltani* ORCID, Mostafa Zakariazadeh, Javad Shokri
Bioimpacts. 2023;13(2): 109-121. doi: 10.34172/bi.2022.23383
PMCID: PMC10182447     PMID: 37193080     Scopus ID: 85152094869    
Interaction of the Fingolimod with HSA was studied using multi-spectroscopic and molecular modeling methods. Fingolimod binds to the binding site II of HSA via hydrogen bonds and Van der Walls forces. The binding is enthalpy driven. Fingolimod interaction with HSA leads to the conformational change of HSA.
Original Research
Yosef Masoudi-Sobhanzadeh* ORCID, Hosein Esmaeili ORCID, Ali Masoudi-Nejad* ORCID
BioImpacts. 2022;12(4): 315-324. doi: 10.34172/bi.2021.40
PMCID: PMC9376160     PMID: 35975205     Scopus ID: 85137344477    
The required data, including proteins and enzymes, are divided into smaller parts and are mined using the existing processors. The proposed method computes the alignment similarity between the existing proteins and SARS-CoV-2’s proteins based on the proposed fuzzy logic system.
Original Research
Muhammad H. Sultan ORCID, Wael A. Mahdi, Young M. Kwon* ORCID
BioImpacts. 2021;11(1): 59-64. doi: 10.34172/bi.2021.08
PMCID: PMC7803925     PMID: 33469509     Scopus ID: 85099254422    
Pluronic F127 limits tissue enzymes to act on protamine on NPH insulin microcrystals to prevent acceleration of insulin release and help control blood glucose in STZ-induced diabetic rats uponsubcutaneous administration.
Original Research
Wael A. Mahdi ORCID, Mohammad S. Absar, Suna Choi, Victor C. Yang, Young M. Kwon* ORCID
BioImpacts. 2022;12(6): 479-486. doi: 10.34172/bi.2022.23477
PMCID: PMC9809136     PMID: 36644546     Scopus ID: 85143309781    
The tPA was successfully modified via enzymatic oxidation by GO, resulting in enhanced control of its activity in the prodrug construct. This approach can be applied to other therapeutic glycoproteins.
Mini Review
Yadollah Omidi* ORCID, Hossein Omidian
BioImpacts. 2021;11(3): 227-233. doi: 10.34172/bi.2021.29
PMCID: PMC8314036     PMID: 34336611     Scopus ID: 85109081223    
Transformation of the academic pharmaceutical and biomedical research centers towards innovative R & D hubs is a dynamic nested complex matter, which can be accomplished via a partnership with pharmaceutical and biomedical manufacturers as well as established and emerging contract research organizations.
Original Research
Atena Sharifi-Rad ORCID, Zeinab Amiri-Tehranizadeh, Atiye Talebi, Niknaz Nosrati, Morvarid Medalian, Mahtab Pejhan, Nazanin Hamzkanloo, Mohammad Reza Saberi, Parisa Mokaberi, Jamshidkhan Chamani* ORCID
Bioimpacts. 2023;13(1): 5-16. doi: 10.34172/bi.2022.23592
PMCID: PMC9923809     PMID: 36817002     Scopus ID: 85152114849    
The MD simulation and spectroscopic studies of the interaction of ct-DNA and propyl acridone revealed that a transition from the extended nucleic double helix towards the denatured structure.
Review
Luigi X Cubeddu* ORCID, Daisy de la Rosa, Michele Ameruoso
Bioimpacts. 2022;12(1): 9-20. doi: 10.34172/bi.2021.23630
PMCID: PMC8783084     PMID: 35087712     Scopus ID: 85127123894    
A combination of old age, comorbidities, increased cytokine levels and proarrhythmic drug therapies canexplain the increased arrhythmic events reported in severe COVID-19 disease.
Original Research
Fatima Molavi ORCID, Mohammad Barzegar-Jalali ORCID, Hamed Hamishehkar* ORCID
BioImpacts. 2022;12(6): 501-513. doi: 10.34172/bi.2022.23733
PMCID: PMC9809140     PMID: 36644544     Scopus ID: 85143373141    
Evaluation of different variables on preparation of Microspheres. F9; Freeze-dried particles prepared by W/O/W emulsion method, F1; Dried particles on the tray at room temperature, F16; Freeze-dried particles prepared by S/O/O emulsion method. W/O/W; Water in oil in water, S/O/O; Solid in oil in oil.
Letter to the Editor
Aleksandr L. Urakov* ORCID, Natalya A. Urakova, Ilnur I. Yagudin, Milena D. Svetova, Darya O. Suntsova
BioImpacts. 2022;12(4): 393-394. doi: 10.34172/bi.2022.23877
PMCID: PMC9376158     PMID: 35975207     Scopus ID: 85138077187    
The purpose of this letter was to present a model for evaluating the biological activity of drugs, which can become a new vector for the development of effective ways to increase blood oxygenation across pulmonary and save the lives of patients with severe atypical pneumonia complicated by respiratory obstruction in COVID-19.
Original Article
Jurica Novak* ORCID, Alena R. Zykova ORCID, Vladimir A. Potemkin ORCID, Vladimir V. Sharutin, Olga K. Sharutina
Bioimpacts. 2023;13(5): 373-382. doi: 10.34172/bi.2023.24180
PMCID: PMC10509740     PMID: 37736338     Scopus ID: 85172785161    
Original Article
Mitra Torabi ORCID, Ayuob Aghanejad*, Pouria Savadi ORCID, Abolfazl Barzegari, Yadollah Omidi ORCID, Jaleh Barar* ORCID
Bioimpacts. 2023;13(3): 255-267. doi: 10.34172/bi.2023.25298
PMCID: PMC10329750     PMID: 37431477     Scopus ID: 85158830047    
Owing to their unique advantages, mesoporous silica nanoparticles (MSNPs) have attracted much attention for drug delivery and targeting. In the current study, MSNPs were fabricated, PEGylated, loaded with sunitinib, and conjugated with mucin-16 aptamer to target CA125 on ovarian cancer cells.
Original Article
Navid Mohammadjani ORCID, Sahand Karimi, Musa Moetasam Zorab ORCID, Morahem Ashengroph* ORCID, Mehran Alavi* ORCID
Bioimpacts. 2024;14(2): 27778. doi: 10.34172/bi.2023.27778
PMCID: PMC10945298     PMID: 38505671     Scopus ID: 85175876168    
PDF
XML
Cited By:
Original Article
Sara Shamsian ORCID, Babak Sokouti, Siavoush Dastmalchi* ORCID
Bioimpacts. 2024;14(2): 29955. doi: 10.34172/bi.2023.29955
PMCID: PMC10945300     PMID: 38505677     Scopus ID: 85175804718    
Review
Navid Mosallaei ORCID, Amirhossein Malaekeh-Nikouei ORCID, Setayesh Sarraf Shirazi, Javad Behmadi, Bizhan Malaekeh-Nikouei* ORCID
Bioimpacts. 2024;14(6): 30136. doi: 10.34172/bi.2024.30136
PMCID: PMC11530970     PMID: 39493899     Scopus ID: 85209575998    
PDF
XML
Cited By:
Original Article
Saman Heydari ORCID, Mohammad Barzegar-Jalali, Mostafa Heydari, Afsaneh Radmehr, Ana Cláudia Paiva-Santos, Maryam Kouhsoltani, Hamed Hamishehkar* ORCID
Bioimpacts. 2024;14(6): 30243. doi: 10.34172/bi.2024.30243
PMCID: PMC11530971     PMID: 39493898     Scopus ID: 85209250796    
PDF
XML
Cited By:


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge